Tirzepatide

Tirzepatide is a dual GIP/GLP-1 receptor agonist researched for its role in glucose metabolism and body weight regulation. Studies indicate it may produce significant reductions in body weight and HbA1c levels. It represents a novel approach to metabolic research by targeting two incretin pathways simultaneously.